Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase

Journal of Animal Science

Volumn 85, Issue 4, 2007, Pages 919-927

  Du, M ^a   Shen, Q W ^a   Zhu, M J ^a   Ford, S P ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Adenosine monophosphate activated protein kinase; Leucine; Mammalian target of rapamycin; Myoblast cell; Protein synthesis

Indexed keywords

MAMMALIA;

5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; MULTIENZYME COMPLEX; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RIBONUCLEOTIDE; S6 KINASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; MOUSE; MYOBLAST; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CELL LINE; ENZYME ACTIVATION; LEUCINE; MICE; MULTIENZYME COMPLEXES; MYOBLASTS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOTIDES; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34247241597     PISSN: 00218812     EISSN: None     Source Type: Journal    
DOI: 10.2527/jas.2006-342     Document Type: Article

References (37)

1. Anthony, J. C., T. G. Anthony, S. R. Kimball, and L. S. Jefferson. 2001. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 131:856S-860S.
2. Bodine, S. C., T. N. Stitt, M. Gonzalez, W. O. Kline, G. L. Stover, R. Bauerlein, E. Zlotchenko, A. Scrimgeour, J. C. Lawrence, D. J. Glass, and G. D. Yancopoulos. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3:1014-1019.
3. Bolster, D. R., S. J. Crozier, S. R. Kimball, and L. S. Jefferson. 2002. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277:23977-23980.
4. Bolster, D. R., N. Kubica, S. J. Crozier, D. L. Williamson, P. A. Farrell, S. R. Kimball, and L. S. Jefferson. 2003. Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle. J. Physiol. 553:213-220.
5. Browne, G. J., S. G. Finn, and C. G. Proud. 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279:12220-12231.
6. Cheng, S. W., L. G. Fryer, D. Carling, and P. R. Shepherd. 2004. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279:15719-15722.
7. Du, M., M. J. Zhu, W. J. Means, B. W. Hess, and S. P. Ford. 2004. Effect of nutrient restriction on calpain and calpastatin content of skeletal muscle from cows and fetuses. J. Anim. Sci. 82:2541-2547.
8. Enfalt, A. C., K. Lundstrom, I. Hansson, S. Johansen, and P. E. Nystrom. 1997. Comparison of non-carriers and heterozygous carriers of the RN- allele for carcass composition, muscle distribution and technological meat quality in Hampshire-sired pigs. Livest. Prod. Sci. 47:221-229.
9. Gao, X., Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R. S. Yeung, B. Ru, and D. Pan. 2002. Tsc tumour suppressor proteins antagonize amino-add-TOR signalling. Nat. Cell Biol. 4:699-704.
10. Hao, L., M. Du, A. Lopez-Campistrous, and C. Fernandez-Patron. 2004. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ. Res. 94:68-76.
11. Hara, K., Y. Maruki, X. Long, K. Yoshino, N. Oshiro, S. Hidayat, C. Tokunaga, J. Avruch, and K. Yonezawa. 2002. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177-189.
12. Hardie, D. G. 2004. AMP-activated protein kinase: A key system mediating metabolic responses to exercise. Med. Sci. Sports Exerc. 36:28-34.
13. Hardie, D. G. 2005. New roles for the LKB1→AMPK pathway. Curr. Opin. Cell Biol. 17:167-173.
14. Hasegawa, H., T. Matsukawa, Y. Shinohara, and T. Hashimoto. 2002. Kinetics of sequential metabolism from D-leucine to L-leucine via alpha-ketoisocaproic acid in rat. Drug Metab. Dispos. 30:1436-1440.
15. Horman, S., G. Browne, U. Krause, J. Patel, D. Vertommen, L. Bertrand, A. Lavoinne, L. Hue, C. Proud, and M. Rider. 2002. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis, Curr. Biol. 12:1419-1423.
16. Inoki, K., T. Zhu, and K. L. Guan. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590.
17. Jefferies, H. B., S. Fumagalli, P. B. Dennis, C. Reinhard, R. B. Pearson, and G. Thomas. 1997. Rapamycin suppresses 5′ TOP mRNA translation through inhibition of p70s6k. EMBO J. 16:3693-3704.
18. Kim, J., R. S. Soils, E. B. Arias, and G. D. Cartee. 2004. Postcontraction insulin sensitivity: Relationship with contraction protocol, glycogen concentration, and 5′ AMP-activated protein kinase phosphorylation. J. Appl. Physiol. 96:575-583.
19. Lang, C. H., and R. A. Frost. 2005. Endotoxin disrupts the leucinesignaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J. Cell. Physiol. 203:144-155.
20. Lynch, C. J., B. Halle, H. Fujii, T. C. Vary, R. Wallin, Z. Damuni, and S. M. Hutson. 2003. Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. Am. J. Physiol. Endocrinol. Metab. 285:E854-E863.
21. Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P. P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179-193.
22. Martin, D. E., and M. N. Hall. 2005. The expanding TOR signaling network. Curr. Opin. Cell Biol. 17:158-166.
23. McManus, E. J., and D. R. Alessi. 2002. TSC1-TSC2: A complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:E214-E216.
24. Milan, D., J. T. Jeon, C. Looft, V. Amarger, A. Robic, M. Thelander, C. Rogel-Gaillard, S. Paul, N. Iannuccelli, L. Rask, H. Ronne, K. Lundstrom, N. Reinsch, J. Gellin, E. Kalm, P. L. Roy, P. Chardon, and L. Andersson. 2000. A mutation in PRKAG3 assoelated with excess glycogen content in pig skeletal muscle. Science 288:1248-1251.
25. Mu, J., J. T. Brozinick, Jr., O. Valladares, M. Bucan, and M. J. Birnbaum. 2001. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7:1085-1094.
26. O'Connor, P. M., J. A. Bush, A. Suryawan, H. V. Nguyen, and T. A. Davis. 2003. Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs. Am. J. Physiol. Endocrinol. Metab. 284:E110-E119.
27. Sakamoto, K., W. G. Aschenbach, M. F. Hirshman, and L. J. Goodyear. 2003. Akt signaling in skeletal muscle: Regulation by exercise and passive stretch. Am. J. Physiol. Endocrinol. Metab. 285:E1081-E1088.
28. Sambandam, N., and G. D. Lopaschuk. 2003. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog. Lipid Res. 42:238-256.
29. Schmelzle, T., and M. N. Hall. 2000. TOR, a central controller of cell growth. Cell 103:253-262.
30. Shen, W. H., D. W. Boyle, P. Wisniowski, A. Bade, and E. A. Liechty. 2005. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J. Endocrinol. 185:275-289.
31. Shen, Q. W., W. J. Means, K. R. Underwood, S. A. Thompson, M. J. Zhu, R. J. McCormick, S. P. Ford, M. Ellis, and M. Du. 2006. Early post-mortem AMP-activated protein kinase (AMPK) activation leads to phosphofructokinase-2 and -1 (PFK-2 and PFK-1) phosphorylation and the development of pale, soft, and exudative (PSE) conditions in porcine longissimus muscle. J. Agric. Food Chem. 54:5583-5589.
32. Sweatt, A. J., M. Wood, A. Suryawan, R. Wallin, M. C. Willingham, and S. M. Hutson. 2004. Branched-chain amino acid catabolism: Unique segregation of pathway enzymes in organ systems and peripheral nerves, Am. J. Physiol. Endocrinol. Metab. 286:E64-E76.
33. Tokunaga, C., K. Yoshino, and K. Yonezawa. 2004. mTOR integrates amino acid- and energy-sensing pathways. Biochem. Biophys. Res. Commun. 313:443-446.
34. Wang, L. Z., and X. Z. Zhu. 2003. Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development. Acta Pharmacol. Sin. 24:965-974.
35. Yang, X., M. J. Zhu, N. Sreejayan, J. Ren, and M. Du. 2005. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol. Cells 20:263-270.
36. Zhu, M. J., S. P. Ford, W. J. Means, B. W. Hess, P. W. Nathanielsz, and M. Du. 2006. Maternal nutrient restriction affects properties of skeletal muscle in offspring. J. Physiol. 575:241-250.
37. Zhu, M. J., S. P. Ford, P. W. Nathanielsz, and M. Du. 2004. Effect of maternal nutrient restriction in sheep on the development of fetal skeletal muscle. Biol. Reprod. 71:1968-1973.